Bangalore: India-based Tata Consultancy Services has been designated as a Leader in Life Science Drug Safety Services (...
The fifth edition of the annual BioSpectrum Asia Pacific clinical research organization (CRO) Survey, which is conduct...
Bangalore: India-based Aurobindo Pharma has received tentative approval from the US Food & Drug Administration for p...
The medical devices industry has progressed by leaps and bounds in the recent past and this is evident from the several ...
Bangalore: India-based Infosys Science Foundation has chosen Dr Satyajit Mayor, professor, cellular organization and sig...
New Delhi: Aethlon Medical, a pioneer in developing selective therapeutic filtration devices to address infectious disea...
With the manate to support and tend start-ups in the biotechnology sector and small and medium enterprises, the Biotech...
Singapore: With an aim to focus on its anti-infectives market, Elder Pharma has announced that it plans to strengthen in...
New Delhi: In what is being criticized as yet another miserable experience created by India's intellectual property and ...
Hyderabad: The Ahmedabad Clinical Pharmacology Unit of GVK Biosciences, Asia's leading contract research organization, h...
New Delhi: BIORx Venture Advisors (BIORx) is going to launch India's first dedicated bio-acceleration program with the t...
Mumbai: BioEnable Technologies, a leading identification and tracking solutions company based in the city of Pune, India...
Giving a clear call for accountability, the Supreme Court of India, on January 3, 2013, sternly reprimanded the Ministry...
Hyderabad: Neuland Laboratories, a pharmaceutical manufacturer providing active pharmaceutical ingredients (APIs), comp...
Singapore: In what is proving to be a major setback for the Indian clinical research industry, reports reveal that the w...
Dr Anuradha Rajput, managing director, Icon Central Laboratories, India, has been working with the company since the pas...
Singapore: The Indian Drug Controller General of India (DCGI) has written a letter to the drug maker Wockhardt to explai...
It was a path-breaking deal that had many eye balls rolling. Industry soothsayers predicted it to be the beginning of an...
